居里 CRIS 深 滬
已收盤 02-06 16:00:00 美东时间
1.03
+0.119
+13.11%
華盛通- 最 高1.05
- 今 開0.94
- 成交量 52.16万股
- 最 低 0.9201
- 昨 收 0.9106
- 總市值 1331.67万
- 52周最高 3.4094
- 市盈率 靜 --
- 換手率 4.03%
- 52周最低 0.771
- 委 比 65.34%
- 總股本 1292.89万
- 歷史最高 565.00
- 量 比 2.41
- 振 幅 14.27%
- 歷史最低 0.771
- 每 手 1
- 風險率 0.63%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多海盐凝聚“核力”打造同位素产业高地
（来源：嘉兴日报） 转自：嘉兴日报 ■记者 周伟达 通讯员 缪尔璇 近日，位于海盐同位素产业园的诺华放射性药品生产项目取得甲级辐射安全许可证，标志着诺华...
02-06 07:14
Cardiff Oncology Announces Executive Leadership Changes as it Transitions to Late-Stage Clinical Development
Cardiff Oncology announced leadership changes amid its growth phase. CEO Mark Erlander and CFO James Levine have stepped down, with Dr. Mani Mohindru, a board member, appointed interim CEO. The company seeks permanent replacements for both roles. Cardiff's lead product, onvansertib, a PLK1 inhibitor, is in mid-stage trials for RAS-mutated colorectal cancer and being evaluated in other cancers. Dr. Mohindru brings extensive biotech experience and ...
01-27 12:00
Curis prices private placement of $80.8M
Curis (NASDAQ:CRIS) on Wednesday entered into a securities purchase agreement for a private investment in public equity (PIPE) for up to $80.8M in gross proceeds, including approximately $20.2M in ini...
01-07 22:38
Curis Provides Updated Data from its Frontline AML Triplet Study
5 of 8 patients (62.5%) achieved Undetectable MRD (uMRD) LEXINGTON, Mass., Dec. 9, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emav...
2025-12-09 21:00
On October 20, 2025, Curis Received Nasdaq Notice Indicating That The Panel Has Granted The Company An Exception Until November 14, 2025T o Regain Compliance With The MVLS Requirement
As previously disclosed, on August 21, 2025, Curis, Inc. (the "Company") received notice from the Listing Qualifications Department (the "Staff") of the Nasdaq Stock Market LLC ("Nasdaq") stating that, because the
2025-10-25 04:07
Curis Appeals Nasdaq Delisting Notice After Non-Compliance
An update from Curis ( ($CRIS) ) is now available. On February 21, 2025, Curis,...
2025-08-23 04:34
Curis Files Prospectus Supplement for Stock Offering
Curis ( ($CRIS) ) has provided an update. On August 8, 2025, Curis, Inc. announ...
2025-08-09 05:48
Curis Q2 EPS $(0.68) Beats $(1.36) Estimate, Sales $2.75M Beat $2.64M Estimate
Curis (NASDAQ:CRIS) reported quarterly losses of $(0.68) per share which beat the analyst consensus estimate of $(1.36) by 50 percent. This is a 66.5 percent increase over losses of $(2.03) per share from the same period
2025-08-05 20:02
Curis Provides Second Quarter 2025 Business Update
Management to host conference call and webcast today at 8:30 a.m. ET LEXINGTON, Mass., Aug. 5, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the develop...
2025-08-05 20:00
